Table 3.
Logistic regression analysis of risk factors related to non-cardiovascular causes mortality during the 3-year follow-up period.
| Variables | Univariate |
||
|---|---|---|---|
| Unit of increase | OR (95% CI) | p Value | |
| High sIL-2R group | Yes versus no | 2.97 (1.59, 5.56) | 0.001 |
| Age | 1 year | 1.08 (1.05, 1.11) | <0.0001 |
| Male | Yes versus no | 1.26 (0.66, 2.39) | 0.481 |
| BMI | 1 kg/m2 | 1.01 (0.92, 1.10) | 0.909 |
| Diabetes | Yes versus no | 2.05 (1.09, 3.83) | 0.025 |
| Hepatitis-seropositive status | Yes versus no | 0.98 (0.33, 2.93) | 0.973 |
| History of cancer | Yes versus no | 1.91 (0.85, 4.26) | 0.115 |
| Dialysis three times weekly | Yes versus no | 0.56 (0.20, 1.57) | 0.271 |
| Dialysis vintage | 1 year | 0.93 (0.86, 1.02) | 0.107 |
| AVF access use | Yes versus no | 1.91 (0.96, 3.78) | 0.065 |
| spKt/V | 1 | 0.99 (0.27, 3.58) | 0.982 |
| ESA dosage | 5000 U/week | 1.26 (0.98, 1.63) | 0.075 |
| Neutrophil counts | 1 × 109/L | 1.07 (0.90, 1.28) | 0.449 |
| Lymphocyte counts | 1 × 109/L | 0.39 (0.19, 0.83) | 0.014 |
| Monocyte counts | 1 × 109/L | 2.37 (0.56, 10.00) | 0.239 |
| Hemoglobin | 1 g/L | 0.98 (0.97, 1.01) | 0.103 |
| hsCRP | 1 mg/L | 1.02 (1.01, 1.03) | 0.005 |
| Albumin | 1 g/L | 0.78 (0.70, 0.86) | <0.0001 |
| SCr | 1 mg/dL | 0.85 (0.77, 0.95) | 0.003 |
| UA | 1 mg/dL | 0.89 (0.73, 1.10) | 0.296 |
| Ferritin | 100 ng/mL | 1.05 (0.94, 1.17) | 0.400 |
| TC | 1 mmol/L | 0.93 (0.69, 1.25) | 0.634 |
| TG | 1 mmol/L | 0.97 (0.77, 1.22) | 0.783 |
| LDL-C | 1 mmol/L | 0.90 (0.62, 1.30) | 0.565 |
| HDL-C | 1 mmol/L | 1.69 (0.72, 3.96) | 0.230 |
| Hcy | 1 μmol/L | 0.99 (0.97, 1.01) | 0.100 |
| β2-MG | 1 mg/L | 1.03 (0.99, 1.07) | 0.169 |
| iPTH | 1 pg/mL | 0.99 (0.88, 1.11) | 0.856 |
| Calcium | 1 mmol/L | 0.50 (0.19, 1.32) | 0.159 |
| Phosphate | 1 mmol/L | 0.72 (0.44, 1.19) | 0.203 |
| Log10NT-proBNP | 1 | 3.06 (1.63, 5.74) | 0.001 |
AVF: arteriovenous fistula; BMI: body-mass index; β2-MG: beta-2-microglobulin; CI: confidence interval; sIL-2R: soluble IL-2 receptor; ESA: erythropoietin-stimulating agent; HDL-C: high-density lipoprotein cholesterol; Hcy: homocysteine; hsCRP: high-sensitivity C-reactive protein; iPTH: intact parathyroid hormone; LDL-C: low-density lipoprotein; NT-proBNP: N-terminal pro brain natriuretic peptide; OR: odds ratio; SCr: serum creatinine; TC: total cholesterol; TG: triglyceride; UA: uric acid.